Literature DB >> 9878399

Screening of a library of phage-displayed peptides identifies human bcl-2 as a taxol-binding protein.

D J Rodi1, R W Janes, H J Sanganee, R A Holton, B A Wallace, L Makowski.   

Abstract

A random library of phage displayed peptides was screened for binding to a biotinylated derivative of paclitaxel (Taxol). Affinity-selected peptides were analyzed for similarity to human proteins. There was no significant similarity between the paclitaxel-selected peptides and tubulin. However, a subset of the peptides was identified that exhibits significant similarity to a non-conserved region of the anti-apoptotic human protein Bcl-2: ELISA assays confirmed binding of paclitaxel to Bcl-2, and circular dichroism spectroscopy demonstrated that a substantial conformational change accompanies this binding. In vivo, treatment with paclitaxel has been shown to lead to Bcl-2 inactivation with concomitant phosphorylation of residues in a disordered, regulatory loop region of the protein. Similarity between paclitaxel-selected peptides and this loop region implicate these residues in drug binding, and suggest that the apoptotic action of paclitaxel may involve the binding of paclitaxel to Bcl-2. These results demonstrate that peptides displayed on the surface of bacteriophage particles can mimic the ligand-binding properties of disordered regions of proteins. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9878399     DOI: 10.1006/jmbi.1998.2303

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  39 in total

1.  Paclitaxel and TRAIL synergize to kill paclitaxel-resistant small cell lung cancer cells through a caspase-independent mechanism mediated through AIF.

Authors:  Terri B Hunter; Neil J Manimala; Kimberly A Luddy; Tracy Catlin; Scott J Antonia
Journal:  Anticancer Res       Date:  2011-10       Impact factor: 2.480

2.  Heat shock protein 90 mediates macrophage activation by Taxol and bacterial lipopolysaccharide.

Authors:  C A Byrd; W Bornmann; H Erdjument-Bromage; P Tempst; N Pavletich; N Rosen; C F Nathan; A Ding
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

3.  Paclitaxel induces calcium oscillations via an inositol 1,4,5-trisphosphate receptor and neuronal calcium sensor 1-dependent mechanism.

Authors:  Wolfgang Boehmerle; Ute Splittgerber; Michael B Lazarus; Kathleen M McKenzie; David G Johnston; David J Austin; Barbara E Ehrlich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

Review 4.  Mitochondria: pharmacological manipulation of cell death.

Authors:  Lisa Bouchier-Hayes; Lydia Lartigue; Donald D Newmeyer
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

5.  Utilizing Yeast Surface Human Proteome Display Libraries to Identify Small Molecule-Protein Interactions.

Authors:  Scott Bidlingmaier; Bin Liu
Journal:  Methods Mol Biol       Date:  2015

6.  Development of a peptide-mediated capture PCR for detection of Mycobacterium avium subsp. paratuberculosis in milk.

Authors:  Janin Stratmann; Birgit Strommenger; Karen Stevenson; Gerald-F Gerlach
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

Review 7.  Intrinsically disordered proteins are potential drug targets.

Authors:  Steven J Metallo
Journal:  Curr Opin Chem Biol       Date:  2010-07-02       Impact factor: 8.822

Review 8.  Microtubule drugs: action, selectivity, and resistance across the kingdoms of life.

Authors:  V Dostál; L Libusová
Journal:  Protoplasma       Date:  2014-03-21       Impact factor: 3.356

9.  Conformational analysis of the carboxy-terminal tails of human beta-tubulin isotypes.

Authors:  Tyler Luchko; J Torin Huzil; Maria Stepanova; Jack Tuszynski
Journal:  Biophys J       Date:  2007-11-09       Impact factor: 4.033

10.  A phase I pharmacokinetic and pharmacodynamic correlative study of the antisense Bcl-2 oligonucleotide g3139, in combination with carboplatin and paclitaxel, in patients with advanced solid tumors.

Authors:  Glenn Liu; Jill Kolesar; Douglas G McNeel; Catherine Leith; Kathy Schell; Jens Eickhoff; Fred Lee; Anne Traynor; Rebecca Marnocha; Dona Alberti; James Zwiebel; George Wilding
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.